FORMULATION AND EVALUATION OF ION-SENSITIVE IN-SITU NASAL GEL OF ZOLMITRIPTAN

In situ gel system is novel drug delivery system in which there is transition of sol to gel on external stimuli like change in pH, temperature or change in ion concentration (sol-gel transition). In the present study various formulations were prepared by using gellan gum as gelling agent and HPMC K100 as controlled or sustained release polymer. All the formulations were evaluated for various parameters like pH, viscosity, drug content, gel strength, mucoadhesive strength and drug release. At minimum concentration of polymer lose their integrity and at maximum concentration stiff gel were formed. At optimized concentration of gelling agent and HPMC K100 showed in situ gelling with all parameter in range. In Vitro release data revealed that the optimized formulation showed controlled and sustained drug release pattern. The optimized formulation also obeyed korsmer Peppas model equation and which showed the release exponent n value 0.765. Thus the ex vivo higher bioavailability can be expected from the optimized formulation.Â

Ohmic Heating Technology and Its Application in Meaty Food: A Review

The purpose of the current review paper is to investigate and analyze about the effects of ohmic heating (OH) different application in the field of fish, meat and its product and compare it with other conventional thermal methods of food processing such as thawing, heating, cooking etc. Food quality, food safety, convenience, freshness, healthy food, natural flavor and taste with extended shelf-life are the main criteria for the demand made by today’s consumers. Ohmic heating is a substitute of conventional heating method of food commodities. It has shorter heating times, avoid hot surfaces and help to minimize temperature gradients. Product parameters such as electrical, thermo-physical and rheological properties of the food and process parameters such as the current frequency, electrode material and the geometry of ohmic chamber affect the process. as a result various application of OH are found such as heating, evaporation, dehydration, extraction, waste water treatment, thawing, cooking of different type fish and meat and its product such as meat ball, hamburger patties surmi, beef, turkey etc

Effect of precision land leveling and permanent raised bed planting on soil properties, input use efficiency, productivity and profitability under maize (Zea mays) – wheat (Triticum aestivum) cropping system

Precision land leveling with permanent raised bed planting with recommended dose of NPK can be used to improve crop yield,water and nutrient use efficiency over the existing traditional land leveling with flat beds planting with recommended dose of NPK practices. The objective of present study was to establish an understanding of maize (Zea mays L.) -wheat (Triticum aestivum L.) rotation yield and input use efficiency can be improved and how land leveling and crop establishment practices can be modified to be more efficient in water use through precision conservation crop management techniques. A farmers participatory field experiment was conducted during 2009- 2011 in the jurisdiction of Sardar Vallabhbhai Patel University of Agriculture & Technology, Meerut, UP. Multi crop planter with inclined plate seed metering device machine were given to the farmers and crops were sown on permanent raised beds in maize-wheat cropping system.The data collected from the farmers participatory field experiment showed that there was about 20.4% (295.8 mm/ha for wide beds, i e 107 cm furrow centre gap) water saving and about 16.5% (310.3 mm/ha for narrow beds, i e 37 cm furrow centre gap) with grain yield increase about 13.5% (5.13 and 4.44 tonnes/ha) for wheat crop and 11.8% (4.33 and 3.82 tonnes/ha) for maize crop with precision land leveling raised bed planting compared to traditional land leveling with flat beds planting. The agronomic efficiency (AE) of N (23.4 and 30.4 kg grain/kg N for maize and wheat) and uptake of N, P and K (103.85, 25.6 and 110.7 kg/ha for maize and 112.95, 19.49 and 112.96 kg/ha for wheat) were significantly improved under precision land leveling with raised bed planting technique compared to other practices

Long-Baseline Neutrino Facility (LBNF) and Deep Underground Neutrino Experiment (DUNE) Conceptual Design Report Volume 2: The Physics Program for DUNE at LBNF

The Physics Program for the Deep Underground Neutrino Experiment (DUNE) at the Fermilab Long-Baseline Neutrino Facility (LBNF) is described

Legal Paradigm Shifts and Their Impacts on the Socio-Spatial Exclusion of Asylum Seekers in Denmark

This chapter discusses the genesis of Denmark’s asylum accommodation system and recent legal and socio-spatial changes as a reaction to the increase of arrivals. By elucidating the structures and objectives of asylum accommodation, I present that the state’s further tightening of restrictive reception and accommodation policies significantly impacts the socio-spatial configurations of accommodations, refugees’ access to housing and their well-being. I discuss the links between the tensioning of laws, the reduction of living conditions and the (re-)constitution of large accommodations as means of socio-spatial exclusion. Applying the case of Denmark’s Hovedstaden Region (Capital Region), I finally argue that asylum accommodation is a central instrument of Denmark’s approaches to strategically isolate forced migrants and to deter them from migrating to Denmark

Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics

Osteosarcoma (OSA) is a rare cancer in people. However OSA incidence rates in dogs are 27 times higher than in people. Prognosis in both species is poor, with five year osteosarcoma survival rates in people not having improved in decades. For dogs, one year survival rates are only around ~45%. Improved and novel treatment regimens are urgently required to improve survival in both humans and dogs with OSA. Utilising information from genetic studies could assist in this in both species, with the higher incidence rates in dogs contributing to the dog population being a good model of human disease. This review compares the clinical characteristics, gross morphology and histopathology, aetiology, epidemiology, and genetics of canine and human osteosarcoma. Finally, the current position of canine osteosarcoma genetic research is discussed and areas for additional work within the canine population are identified

Performance of the CMS muon trigger system in proton-proton collisions at √s = 13 TeV

The muon trigger system of the CMS experiment uses a combination of hardware and software to identify events containing a muon. During Run 2 (covering 2015–2018) the LHC achieved instantaneous luminosities as high as 2 × 10$^{34}$ while delivering proton-proton collisions at √(s) = 13. The challenge for the trigger system of the CMS experiment is to reduce the registered event rate from about 40MHz to about 1kHz. Significant improvements important for the success of the CMS physics program have been made to the muon trigger system via improved muon reconstruction and identification algorithms since the end of Run 1 and throughout the Run 2 data-taking period. The new algorithms maintain the acceptance of the muon triggers at the same or even lower rate throughout the data-taking period despite the increasing number of additional proton-proton interactions in each LHC bunch crossing. In this paper, the algorithms used in 2015 and 2016 and their improvements throughout 2017 and 2018 are described. Measurements of the CMS muon trigger performance for this data-taking period are presented, including efficiencies, transverse momentum resolution, trigger rates, and the purity of the selected muon sample. This paper focuses on the single- and double-muon triggers with the lowest sustainable transverse momentum thresholds used by CMS. The efficiency is measured in a transverse momentum range from 8 to several hundred

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

Background Up-to-date evidence on levels and trends for age-sex-specific all-cause and cause-specific mortality is essential for the formation of global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013) we estimated yearly deaths for 188 countries between 1990, and 2013. We used the results to assess whether there is epidemiological convergence across countries. Methods We estimated age-sex-specific all-cause mortality using the GBD 2010 methods with some refinements to improve accuracy applied to an updated database of vital registration, survey, and census data. We generally estimated cause of death as in the GBD 2010. Key improvements included the addition of more recent vital registration data for 72 countries, an updated verbal autopsy literature review, two new and detailed data systems for China, and more detail for Mexico, UK, Turkey, and Russia. We improved statistical models for garbage code redistribution. We used six different modelling strategies across the 240 causes; cause of death ensemble modelling (CODEm) was the dominant strategy for causes with sufficient information. Trends for Alzheimer's disease and other dementias were informed by meta-regression of prevalence studies. For pathogen-specific causes of diarrhoea and lower respiratory infections we used a counterfactual approach. We computed two measures of convergence (inequality) across countries: the average relative difference across all pairs of countries (Gini coefficient) and the average absolute difference across countries. To summarise broad findings, we used multiple decrement life-tables to decompose probabilities of death from birth to exact age 15 years, from exact age 15 years to exact age 50 years, and from exact age 50 years to exact age 75 years, and life expectancy at birth into major causes. For all quantities reported, we computed 95% uncertainty intervals (UIs). We constrained cause-specific fractions within each age-sex-country-year group to sum to all-cause mortality based on draws from the uncertainty distributions. Findings Global life expectancy for both sexes increased from 65·3 years (UI 65·0-65·6) in 1990, to 71·5 years (UI 71·0-71·9) in 2013, while the number of deaths increased from 47·5 million (UI 46·8-48·2) to 54·9 million (UI 53·6-56·3) over the same interval. Global progress masked variation by age and sex: for children, average absolute differences between countries decreased but relative differences increased. For women aged 25-39 years and older than 75 years and for men aged 20-49 years and 65 years and older, both absolute and relative differences increased. Decomposition of global and regional life expectancy showed the prominent role of reductions in age-standardised death rates for cardiovascular diseases and cancers in high-income regions, and reductions in child deaths from diarrhoea, lower respiratory infections, and neonatal causes in low-income regions. HIV/AIDS reduced life expectancy in southern sub-Saharan Africa. For most communicable causes of death both numbers of deaths and age-standardised death rates fell whereas for most non-communicable causes, demographic shifts have increased numbers of deaths but decreased age-standardised death rates. Global deaths from injury increased by 10·7%, from 4·3 million deaths in 1990 to 4·8 million in 2013; but age-standardised rates declined over the same period by 21%. For some causes of more than 100 000 deaths per year in 2013, age-standardised death rates increased between 1990 and 2013, including HIV/AIDS, pancreatic cancer, atrial fibrillation and flutter, drug use disorders, diabetes, chronic kidney disease, and sickle-cell anaemias. Diarrhoeal diseases, lower respiratory infections, neonatal causes, and malaria are still in the top five causes of death in children younger than 5 years. The most important pathogens are rotavirus for diarrhoea and pneumococcus for lower respiratory infections. Country-specific probabilities of death over three phases of life were substantially varied between and within regions. Interpretation For most countries, the general pattern of reductions in age-sex specific mortality has been associated with a progressive shift towards a larger share of the remaining deaths caused by non-communicable disease and injuries. Assessing epidemiological convergence across countries depends on whether an absolute or relative measure of inequality is used. Nevertheless, age-standardised death rates for seven substantial causes are increasing, suggesting the potential for reversals in some countries. Important gaps exist in the empirical data for cause of death estimates for some countries; for example, no national data for India are available for the past decade. Funding Bill & Melinda Gates Foundation